Over the last decade, the field of cell and gene therapy has rapidly grown, and it holds enormous promise for treating many diseases.
In the markets and markets bioprocessing conference of 2017, the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases was assessed. But, there are still factors like manufacturing maze, investment, logistics and regulatory challenges that prevent the cell and gene therapies to be widely used.
The 2020 conference has put together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges. Learn from the leading experts of the industry about strategies, technologies, and innovations in the area of bioprocessing of cell-gene therapies.